ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Shuo Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6738-1747; OpenAlex author ID A5056937817. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Targeting IRF7 to overcome gemcitabine resistance in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.isci.2025.114207 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ganghua Yang · 1 shared paper, 2025 · strength 0.30
- Paper Targeting IRF7 to overcome gemcitabine resistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.114207 ↗
Qinhong Xu · 1 shared paper, 2025 · strength 0.30
- Paper Targeting IRF7 to overcome gemcitabine resistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.114207 ↗
Zheng Wang · 1 shared paper, 2025 · strength 0.30
- Paper Targeting IRF7 to overcome gemcitabine resistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.114207 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.